Press Releases

Showing 36-70 of 180


2013

July

July 17

Abbott Reports Second-Quarter 2013 Results

July 15

Abbott to Enter Laser Cataract Surgery Market through Acquisition of OptiMedica

July 15

Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio

July 10

Abbott Announces Approval of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System in Japan
 

June

June 28

Abbott Hosts Conference Call for Second-Quarter Earnings

June 21

Abbott Recognizes Winners of Supplier Excellence Awards

June 20

Abbott Announces New Test to Help Doctors Determine Personalized Treatment Path for Patients with Hepatitis C

June 14

Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend

June 11

Abbott Initiates Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold

June 10

Abbott to Present at Wells Fargo Securities Research & Economics 2013 Healthcare Conference

June 4

Abbott to Present at William Blair 33rd Annual Growth Stock Conference

June 4

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 3

Abbott Previews Next-Generation Blood Screening Prototype during International Society of Blood Transfusion Meeting
 

May

May 31

Abbott to Present at Goldman Sachs 34th Annual Global Healthcare Conference

May 22

Abbott to Present at Deutsche Bank 38th Annual Health Care Conference

May 21

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 9

Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes

May 8

Abbott to Present at UBS Global Healthcare Conference

May 7

New Parenting Survey Reveals That Nearly All Moms Feel Judged on Parenting Decisions
 

April

April 18

Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients

April 17

Abbott Reports First-Quarter 2013 Results

April 16

Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand

April 15

Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States

April 10

Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient

April 1

Abbott Hosts Conference Call for First-Quarter Earnings
 

March

March 28

New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues

March 20

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 11

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 10

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

March 7

Abbott to Present at Barclays Capital 2013 Global Healthcare Conference

March 4

Abbott Introduces Nutrition for Active Kids - Kidz ZonePerfect® Nutrition Bars
 

February

February 21

Abbott to Collaborate with Janssen and Pharmacyclics on Development of Companion Test for Investigational Leukemia Therapy

February 15

Abbott Declares 357th Consecutive Quarterly Dividend

February 12

New Survey Reveals Eight in 10 Fitness Enthusiasts Are Not Doing Enough to Aid Recovery After Exercise
 

January

January 23

Abbott Reports Fourth-Quarter and Full-Year 2012 Results